6838 Formosa Pharmaceuticals
Formosa Pharmaceuticals (6838) held its annual general meeting on May 25, 115, approving the 114 fiscal year financial statements and loss compensation plan. The meeting also approved the removal of non-compete restrictions for directors and updated several internal governance procedures.
📋 Article Processing Timeline
- 📰 Published: May 26, 2026 at 06:31
- 🔍 Collected: May 26, 2026 at 06:31 (0 min after Published)
- 🤖 AI Analyzed: May 31, 2026 at 20:20 (133h 48m after Collected)
1. Date of AGM: 05/25/115. 2. Earnings distribution or loss compensation: Approved the 114 fiscal year loss compensation plan. 3. Articles of Incorporation amendment: None. 4. Business report and financial statements: Approved the 114 fiscal year reports. 5. Election of directors/supervisors: None. 6. Other matters: Approved the removal of non-compete restrictions for directors (including independent directors). 7. Other notes: Approved amendments to procedures for asset acquisition/disposal, endorsement/guarantee, director election, fund lending, and shareholder meeting rules.
FAQ
When was the Formosa Pharmaceuticals AGM held?
It was held on May 25, 115.